Add BrightSurf on Google Email

Science News Archive 2002 - Page 17


Page 17 of 93

Bacterial protein kills tumors

Researchers at the University of Illinois Chicago have isolated a protein from bacteria that kills cancer cells without causing harm. The protein, azurin, was tested in mice with human melanomas and showed significant tumor shrinkage, with no deaths or adverse reactions.

SourceUniversity of Illinois Chicago·JournalProceedings of the National Academy of Sciences·DateOct 25, 2002

Study shows fossil records remain stable in storm beds

Researchers have found that fossils in storm beds are not randomly distributed, but instead follow a non-random pattern, preserving the original structure of ancient sea floor habitats. This study provides valuable insights into understanding ecological relationships and movement of organism habitats through space and time.

Smog over the Mediterranean

The MINOS study found high levels of air pollution over the Mediterranean Sea, originating from both western and eastern Europe, as well as South Asia. The pollution transport follows prevailing winds and affects ecosystems and human health, while aerosols alter solar radiation absorption and climate patterns.

SourceMax-Planck-Gesellschaft·JournalScience·DateOct 25, 2002

Paleontological data better than expected

A preliminary study of the Paleobiology Database reveals that fragile fossils occur as frequently as durable ones, contradicting the expectation that tough skeletons would be more common. This finding suggests that the fossil record may be a more reliable source of information than previously thought.

Psychological, physical abuse equally harmful to health

A recent study found that psychological abuse is equally damaging to physical health as physical abuse, with both forms of abuse linked to chronic illnesses and poor general health. The study analyzed data from the National Violence Against Women Survey and found that men and women who experienced either form of violence were more like...

SourceCenter for Advancing Health·JournalAmerican Journal of Preventive Medicine·DateOct 24, 2002

Study: Acidic surfaces on atmospheric aerosols greatly increase secondary aerosol formation

Researchers at the University of North Carolina at Chapel Hill have discovered an acid-catalyzed process that brings about secondary organic aerosol formation, potentially generating five to 10 times more aerosol in the atmosphere. The study's findings appear to explain various phenomena leading to aerosol formation and have important ...

New drug stops stroke damage to brain

Researchers have discovered a new drug that can prevent brain damage caused by strokes in the majority of patients. The drug, developed by University of Toronto researchers, works by blocking negative NMDA receptor stimulation, making it a potential practical stroke therapy.

SourceUniversity of Toronto·JournalScience·DateOct 24, 2002

New drug may reverse bone loss without estrogen’s side effects, Science study says

A new study published in the journal Science suggests that estren, a synthetic compound, can build bone and improve bone density and strength without affecting reproductive organs. The findings may indicate a potential alternative to standard hormone replacement therapy for treating osteoporosis in both men and women.

Researchers discover 'doorways' into brain cells

Researchers discovered specialized domains on nerve cell surfaces that regulate the entry of molecules, revising a long-held theory. These 'endocytic zones' control receptor transport and are also entry points for nutrients and pathogens, offering new insights into brain development and neurological disorders.

SourceDuke University·JournalNeuron·DateOct 23, 2002

Agreements for industry-sponsored clinical trials often fail to protect researchers’ independence

A study by Duke University Medical Center found that agreements between academic medical centers and industry sponsors rarely include provisions to protect researchers' independence, access to data, and editorial control. This can lead to compromised scientific integrity and a lack of transparency in clinical trials.

SourceDuke University Medical Center·JournalNew England Journal of Medicine·DateOct 23, 2002